{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T20:57:33Z","timestamp":1777928253810,"version":"3.51.4"},"reference-count":26,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:p>Systemic lupus erythematosus (SLE) is a complex, multisystem autoimmune disorder, which often involves referral to multiple medical specialists. Lupus nephritis (LN) occurs in ~35% of adults with SLE and predicts poor survival. There is currently no consensus on how to manage patients with SLE or LN across specialties and across different European countries. The Lupus Nephritis Terminology Advisory Group was formed to address this issue as it impacts upon LN treatment. It has developed consensus statements based on opinions from expert panel meetings with nephrologists, nephropathologists, rheumatologists, clinical immunologists and internal medicine specialists from many European countries, after reviewing current guidelines from the European League Against Rheumatism, the American College of Rheumatology and the participants\u2019 experience. In this article, we report consensus statements that were developed in six important areas: classification of patients with LN, how classification affects the selection of treatment options and definitions of induction, response, flare and maintenance. We have also proposed a consensus for the terminology involved in the management of LN that is consistent with clinical opinion gathered from multidisciplinary expert meetings and with existing guidelines. We believe this consensus approach provides agreed expert opinion to clinicians and will form the basis for optimising LN treatment.<\/jats:p>","DOI":"10.1177\/0961203308100481","type":"journal-article","created":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T11:18:34Z","timestamp":1234437514000},"page":"257-263","source":"Crossref","is-referenced-by-count":125,"title":["European consensus statement on the terminology used in the management of lupus glomerulonephritis"],"prefix":"10.1177","volume":"18","author":[{"given":"C","family":"Gordon","sequence":"first","affiliation":[{"name":"Rheumatology Research Group, Division of Immunity and Infection, University of Birmingham and Departments of Rheumatology, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust and University Hospital Birmingham NHS Foundation Trust, Birmingham, UK"}]},{"given":"D","family":"Jayne","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Clinical Medicine, University of Cambridge, UK"}]},{"given":"C","family":"Pusey","sequence":"additional","affiliation":[{"name":"Renal Section, Division of Medicine, Imperial College London, Hammersmith Hospital, London, UK"}]},{"given":"D","family":"Adu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK"}]},{"given":"Z","family":"Amoura","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, French National Reference Center for Systemic Lupus, Pitie-Salpetriere Hospital, Paris, France"}]},{"given":"M","family":"Aringer","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine III, University Clinical Center Carl Gustav Carus at the Technical University of Dresden, Germany"}]},{"given":"J","family":"Ballerin","sequence":"additional","affiliation":[{"name":"Nephrology Department, Fundacio Puigvert, Barcelona, Spain"}]},{"given":"R","family":"Cervera","sequence":"additional","affiliation":[{"name":"Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain"}]},{"given":"J","family":"Calvo-Al\u00e9n","sequence":"additional","affiliation":[{"name":"Rheumatology Section, Hospital General Sierrallana, Torrelavega, Spain"}]},{"given":"C","family":"Chizzolini","sequence":"additional","affiliation":[{"name":"Immmunology and Allergy, University Hospital and School of Medicine, Geneva, Switzerland"}]},{"given":"JM","family":"Dayer","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Geneva, Switzerland"}]},{"given":"A","family":"Doria","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Padova, Padova, Italy"}]},{"given":"F","family":"Ferrario","sequence":"additional","affiliation":[{"name":"Renal Immunopathology Centre, Department of Nephrology, San Carlo Borromeo Hospital, Milan, Italy"}]},{"given":"J","family":"Floege","sequence":"additional","affiliation":[{"name":"Medizinische Klinik II, Aachen, Germany"}]},{"given":"L","family":"Guillevin","sequence":"additional","affiliation":[{"name":"Department Internal Medicine, Hospital Cochin, Assistance PUblique Hopitaux de Paris,Paris, France"}]},{"given":"M","family":"Haubitz","sequence":"additional","affiliation":[{"name":"16 Department of Nephrology, Medical School Hannover, Hannover, Germany"}]},{"given":"F","family":"Hiepe","sequence":"additional","affiliation":[{"name":"17 Clinic for Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin, Germany"}]},{"given":"F","family":"Houssiau","sequence":"additional","affiliation":[{"name":"18 Rheumatology Department, Universite Catholique de Louvan, Brussels, Belgium"}]},{"given":"P","family":"Lesavre","sequence":"additional","affiliation":[{"name":"19 Service de Nephrologie, Hopital Necker, Paris, France"}]},{"given":"L","family":"Lightstone","sequence":"additional","affiliation":[{"name":"20 Renal Section, Division of Medicine, Imperial College London, Hammersmith Campus, UK"}]},{"given":"PL","family":"Meroni","sequence":"additional","affiliation":[{"name":"21 Allergy and Clinical Immunology Unit, Department of Internal Medicine, University of Milan, IRCCS Istituto Auxological Italiano, Milan, Italy"}]},{"given":"O","family":"Meyer","sequence":"additional","affiliation":[{"name":"22 Service de rheumatologie, Hopital Bichat, Paris, France"}]},{"given":"B","family":"Moulin","sequence":"additional","affiliation":[{"name":"23 Nephrology Department, CHU Strasbourg, France"}]},{"given":"K","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"24 Apreva Pharmaceuticals, Surrey, UK"}]},{"given":"M","family":"Praga","sequence":"additional","affiliation":[{"name":"25 Hospital 12 de Octubre, Madrid Hospital Virgen de Rocio, Seville, Hospital Gregorio Maranon, Madrid, Spain"}]},{"given":"H","family":"Schulze-Koops","sequence":"additional","affiliation":[{"name":"26 Nikolaus Fiebiger Centre for Molecular Meidcine, University of Erlangen-Nuremberg, Erlangen, Germany"}]},{"given":"RA","family":"Sinico","sequence":"additional","affiliation":[{"name":"27 Clinical Immunology Unit and Renal Unit, Azienda Ospedaliera Ospedale San Carlo Borromeo, Milan, Italy"}]},{"given":"KGC","family":"Smith","sequence":"additional","affiliation":[{"name":"28 Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge, CB2 OXY"}]},{"given":"A","family":"Tincani","sequence":"additional","affiliation":[{"name":"29 Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Italy"}]},{"given":"C","family":"Vasconcelos","sequence":"additional","affiliation":[{"name":"30 Imunologia Clinica, Hospital Geral Santo Antonio, Universidade do Porto, Porto, Portugal"}]},{"given":"G","family":"Hughes","sequence":"additional","affiliation":[{"name":"31 London Lupus Centre, London Bridge Hospital, London, UK"}]}],"member":"179","published-online":{"date-parts":[[2009,3,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0002-9343(82)90812-9","volume":"72","author":"Wallace DJ","year":"1982","journal-title":"Am J Med"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199905000-00002"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/94.1.19"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001777"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2006.04.008"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.070367"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.070367"},{"key":"atypb8","author":"Gordon C","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1002\/art.21625"},{"key":"atypb10","first-page":"447","volume":"86","author":"Hay EM","year":"1993","journal-title":"Q J Med"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1191\/096120300672904669"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606"},{"key":"atypb13","first-page":"657","volume":"20","author":"Hawker G","year":"1993","journal-title":"J Rheumatol"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400506"},{"key":"atypb15","first-page":"373","volume":"27","author":"Gladman DD","year":"2000","journal-title":"J Rheumatol"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928"},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00443.x"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1002\/art.10461"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1177\/0961203306075613"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-7-199610010-00003"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043731"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-006-0142-3"},{"key":"atypb25","unstructured":"25 Appel GB\u2004 Dooley MA\u2004 Ginzler EM\u2004. Mycophenolate Mofetil Compared with Intravenous Cyclophosphamide as Induction Therapy for Lupus Nephritis: Aspreva Lupus Management Study (ALMS) Results. Abstract presented at The American Society of Nephrology 2007, San Francisco, California, USA. Abstract SA-FC057."},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1002\/art.20364"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0961203308100481","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0961203308100481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:08:13Z","timestamp":1777676893000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0961203308100481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1177\/0961203308100481"],"URL":"https:\/\/doi.org\/10.1177\/0961203308100481","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}